DM Scan diabetes risk assessment system

DM Scan diabetes risk assessment system

1. Outline
      With changing lifestyles and an aging population, a variety of chronic non-communicable diseases were prevalent trend, such as diabetes and cardiovascular disease. China has become the largest countries in the world with diabetes. 2008 survey results show that in adults over the age of 20, the age-standardized diabetes prevalence rate of 9.7%, while the proportion of pre-diabetes as much as 15.5%, the equivalent of every four adults had a high blood sugar by state. Even more serious is that 60.7% of patients with diabetes have not been diagnosed early and can not be effective education and treatment. About half of the patients diagnosed with diabetes has emerged more than one or an irreversible complications.
      Clinical studies have shown that skin tissue glycation end product concentration increased early warning signal of diabetes and its complications. AS-200 diabetes noninvasive detector, use safety light irradiation of human skin, the optical signal obtained to reflect the subject glycation end products, while taking common risk of diabetes family history of diabetes, BMI, alcohol and tobacco addiction factors, the final output diabetes risk index, provide follow-up treatment and lifestyle advice. Significant product advantages include: subjects without fasting, without blood (safe, noninvasive, no reagents), to quickly display the test results.
2. The main application areas
  1) diabetes screening
  2) diabetes and its complications Risk Assessment
  3) evaluation of long-term control of diabetes
3. The main technical indicators
  1) Single detection time: <60 seconds
  2) Equipment Power: 220V / 50 Hz
  3) Operating Conditions
        Relative humidity: ≤ 75%
        Ambient temperature: 18 ℃ ~ 30 ℃
        Atmospheric pressure: 860 hPa ~ 1060 hPa